Determinants of direct and indirect costs in anorexia nervosa.

About this resource

OBJECTIVE: To estimate direct and indirect costs of anorexia nervosa (AN), and to identify cost determinants. METHODS: In a subsample (n = 225) of the ANTOP trial (Anorexia Nervosa Treatment of OutPatients) health care utilization and productivity losses were assessed at baseline for the previous 3 months and monetarily valued. Included were females aged 18 years and older diagnosed with AN or subsyndromal AN, and a body mass index (BMI) between 15 and 18.5 kg/m(2) . To account for missing data multiple imputation was employed. Cost determinants were derived from generalized linear models with gamma distribution and log link function. RESULTS: Mean 3-months costs per patient amounted to €5,866 (SE = €576). The largest share of costs (€3,374) resulted from hospitalizations. Determinants of direct costs were analyzed separately for those with hospitalizations for AN, and those without. In the group only treated as outpatients, participants with binge/purge subtype, and those diseased for more than 6 years had higher costs. Moreover, costs were increased in patients with a comorbid mental disorder. In the group with hospitalizations, direct costs increased with BMI. BMI was measured at the end of the observation period, indicating that longer duration of treatment yielded higher weight gain. Indirect costs were not significantly associated with any disease-related characteristic. DISCUSSION: Costs resulting from health care utilization and productivity loss are substantial, although the sample studied had not received sufficient treatment. Future research should analyze the development of costs over time.

AuthorStuhldreher N., Konnopka A., Konig H.-H., Wild B., Zipfel S., Herzog W.
JournalInternational Journal of Eating Disorders
Volume48(1):139-46
Year2015

See also

Effect on bone health of estrogen preparations in premenopausal women with anorexia nervosa: A systematic review and meta-analyses

Objective: Because estrogen therapies are widely prescribed for amenorrhea associated with anorexia nervosa (AN), we conducted a systematic review and meta-analyses to estimate the influence of estrogen preparations (EP) on bone mineral density in women with AN.

Read more

Ego-syntonicity and ego-dystonicity of eating-related intrusive thoughts in patients with eating disorders

The main objective of the present study was to analyse the role of the ego-dystonicity and ego-syntonicity of eating disorder intrusive thoughts (EDITs) in the genesis and maintenance of eating disorders (EDs).

Read more

A systematic review of in vitro cytokine production in eating disorders.

BACKGROUND: Eating disorders (EDs) have been associated with alterations in cytokine concentrations and production.

Read more

Olanzapine versus placebo for out-patients with anorexia nervosa

Anorexia nervosa (AN) is a serious psychiatric illness associated with significant morbidity and mortality.

Read more

Help us improve!

Give us feedback!

We will continue throughout 2020 to update and improve the NEDC website and welcome any feedback you may have on the site.

Provide feedback